{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:22:20Z","timestamp":1779358940664,"version":"3.51.4"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:00:00Z","timestamp":1549324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2019.00020","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T23:38:37Z","timestamp":1549323517000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome Associated With a Novel Mutation of FOXP3 Gene"],"prefix":"10.3389","volume":"7","author":[{"given":"Charalampos","family":"Agakidis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Agakidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosmas","family":"Sarafidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Papoulidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Xinias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelia","family":"Farmaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jaci.2017.10.041","article-title":"Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study","volume":"141","author":"Barzaghi","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B2","first-page":"20","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume-title":"Nat Genet.","author":"Bennett","year":"2001"},{"key":"B3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/ACI.0000000000000214","article-title":"The immunological and genetic basis of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome","volume":"156","author":"Dhuban","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fped.2017.00267","article-title":"Atypical late-onset immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome with intractable diarrhea: a case report","volume":"5","author":"Ge","year":"2017","journal-title":"Front Pediatr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.13011","article-title":"From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation","volume":"1417","author":"Bacchetta","year":"2018","journal-title":"Ann NY Acad Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.clim.2014.12.007","article-title":"Fetal onset IPEX: report of two families and review of literature","volume":"156","author":"Xavier-da-Silva","year":"2015","journal-title":"Clin. Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/S0140-6736(15)60773-5","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome and recurrent intrauterine fetal death","volume":"385","author":"Vasiljevic","year":"2015","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":":226","DOI":"10.1002\/ajmg.a.37401","article-title":"Identification of a novel nonsense mutation in the FOXP3 gene in a fetus with hydrops-Expanding the phenotype of IPEX syndrome","author":"Reichert","year":"2016","journal-title":"Am J Med Genet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fimmu.2015.00185","article-title":"Early-onset autoimmune disease as a manifestation of primary immunodeficiency","volume":"6","author":"Carneiro-Sampaio","year":"2015","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.clim.2011.06.006","article-title":"Identification of FOXP3-negative regulatory T-like (CD4+CD25+CD127low) cells in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome","volume":"141","author":"Otsubo","year":"2011","journal-title":"Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.jaci.2008.09.027","article-title":"Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity","volume":"122","author":"Gambineri","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/MPG.0b013e3181a159de","article-title":"Severe gastritis in an insulin-dependent child with an IPEX syndrome","volume":"49","author":"Scaillon","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1053\/j.gastro.2010.06.006","article-title":"Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy","volume":"139","author":"Moes","year":"2010","journal-title":"Gastroenterology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2133.2008.08835.x","article-title":"Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome","volume":"60","author":"Halabi-Tawil","year":"2009","journal-title":"Br J Dermatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/MPG.0b013e3182250651","article-title":"Autoimmune hepatitis type 2 in a child with IPEX syndrome","volume":"53","author":"Lopez","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2337\/dc08-1188","article-title":"Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes","volume":"32","author":"Rubio-Cabezas","year":"2009","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10875-014-0059-7","article-title":"Clinical heterogeneity of immunodysregulation, polyendocrinopathy, enteropathy, X-linked: pulmonary involvement as a non-classical disease manifestation","volume":"34","author":"Baris","year":"2014","journal-title":"J Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/j.clinre.2015.03.006","article-title":"Long-term disease course in a patient with severe neonatal IPEX syndrome","volume":"39","author":"Duclaux-Loras","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00467-015-3102-x","article-title":"Renal involvement in the immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) disorder","volume":"30","author":"Sheikine","year":"2015","journal-title":"Pediatr Nephrol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00467-009-1119-8","article-title":"Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome","volume":"24","author":"Hashimura","year":"2009","journal-title":"Pediatr Nephrol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.4049\/jimmunol.177.5.3133","article-title":"Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor","volume":"177","author":"Lopes","year":"2006","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/ni1179","article-title":"A well-adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/jmedgenet-2012-100759","article-title":"The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome","volume":"49","author":"d'Hennezel","year":"2012","journal-title":"J Med Genet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.clim.2015.12.014","article-title":"Clinical and structural impact of mutations affecting the residue Phe367 of FOXP3 in patients with IPEX syndrome","volume":"163","author":"Colobran","year":"2016","journal-title":"Clin Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jaci.2017.03.049","article-title":"Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations","volume":"141","author":"Leiding","year":"2018","journal-title":"J Allergy Clin Immunol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00020\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T23:38:38Z","timestamp":1549323518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00020\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,5]]},"references-count":26,"alternative-id":["10.3389\/fped.2019.00020"],"URL":"https:\/\/doi.org\/10.3389\/fped.2019.00020","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,5]]},"article-number":"20"}}